IRIS PubliCatt

Petito, Valentina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.018
NA - Nord America 1.863
AS - Asia 607
Continente sconosciuto - Info sul continente non disponibili 11
SA - Sud America 9
AF - Africa 6
OC - Oceania 2
Totale 4.516
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.840
DE - Germania 475
IT - Italia 469
SE - Svezia 387
CN - Cina 378
PL - Polonia 160
FR - Francia 124
IE - Irlanda 101
UA - Ucraina 101
SG - Singapore 81
GB - Regno Unito 63
RU - Federazione Russa 45
IN - India 44
TR - Turchia 40
FI - Finlandia 32
BE - Belgio 20
CA - Canada 17
IR - Iran 15
HK - Hong Kong 13
KR - Corea 13
NL - Olanda 12
EU - Europa 11
ES - Italia 10
JP - Giappone 8
BR - Brasile 7
CZ - Repubblica Ceca 5
MX - Messico 5
CI - Costa d'Avorio 4
CH - Svizzera 3
HU - Ungheria 3
RO - Romania 3
VN - Vietnam 3
IL - Israele 2
KW - Kuwait 2
PT - Portogallo 2
TH - Thailandia 2
AL - Albania 1
AU - Australia 1
BD - Bangladesh 1
CL - Cile 1
EC - Ecuador 1
GL - Groenlandia 1
GR - Grecia 1
ID - Indonesia 1
IQ - Iraq 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
RS - Serbia 1
SA - Arabia Saudita 1
TN - Tunisia 1
TW - Taiwan 1
UG - Uganda 1
Totale 4.516
Salva come PNG Salva come JPEG
Città #
Chandler 463
Ashburn 153
Warsaw 142
Cattolica 105
Dublin 101
Beijing 90
Jacksonville 81
Ann Arbor 77
Rome 76
New York 62
San Mateo 55
Singapore 54
Wilmington 50
Boston 45
Nanjing 44
Hangzhou 39
Izmir 38
Woodbridge 38
Princeton 36
Marseille 35
Milan 35
Moscow 35
Dearborn 34
Fairfield 31
Redwood City 27
Houston 26
Nürnberg 25
Shanghai 25
Boardman 24
Seattle 24
Lawrence 23
Munich 20
Kraków 17
Lancaster 17
Nanchang 17
Shenyang 17
Redmond 16
Bremen 15
Brussels 15
London 15
Mountain View 14
Zhengzhou 13
Guangzhou 12
Cambridge 11
Fremont 11
Kish 11
Norwalk 11
Augusta 10
Hebei 10
Pune 10
Tianjin 10
Chicago 9
Jiaxing 9
Kunming 9
Los Angeles 9
Helsinki 8
Leawood 8
Monza 8
Andover 7
Paris 7
Seoul 7
Washington 7
Hong Kong 6
San Diego 6
Verona 6
Changsha 5
Hounslow 5
Jinan 5
Trieste 5
Abidjan 4
Changchun 4
Lanzhou 4
Mexico City 4
Montecorvino Rovella 4
Naples 4
Baronissi 3
Brno 3
Budapest 3
Busto Arsizio 3
Clearwater 3
Falls Church 3
Fiano Romano 3
Grazzanise 3
Hefei 3
Kharkov 3
Lecco 3
Monmouth Junction 3
São Paulo 3
Tokyo 3
Trento 3
Unirea 3
Wageningen 3
Aachen 2
Amsterdam 2
Bath 2
Bentivoglio 2
Capurso 2
Casarano 2
Cassino 2
Castelfidardo 2
Totale 2.582
Salva come PNG Salva come JPEG
Nome #
Gut microbial flora, prebiotics, and probiotics in IBD: their current usage and utility 292
Gut Microbiota Modulation and Mucosal Immunity: Focus on Rifaximin 157
Anti-TNF-α-induced psoriasiform lesions in IBD: an abnormal immune activation or a 'patchy cutaneous' immune suppression? 151
Gut microbiota compositional and functional fingerprint in patients with alcohol use disorder and alcohol-associated liver disease 142
Efficacy and Mechanisms of Action of Fecal Microbiota Transplantation in Ulcerative Colitis: Pitfalls and Promises From a First Meta-Analysis 129
13C-octanoic acid breath test to study gastric emptying time 126
Gut Microbiota in Health, Diverticular Disease, Irritable Bowel Syndrome, and Inflammatory Bowel Diseases: Time for Microbial Marker of Gastrointestinal Disorders? 126
Gelatin tannate ameliorates acute colitis in mice by reinforcing mucus layer and modulating gut microbiota composition: Emerging role for 'gut barrier protectors' in IBD? 125
Role and mechanisms of action of Escherichia coli nissle 1917 in the maintenance of remission in ulcerative colitis patients: an update 113
Nutrition and IBD: Malnutrition and/or Sarcopenia? A Practical Guide 111
The therapeutic management of gut barrier leaking: the emerging role for mucosal barrier protectors 108
Skeletal muscle-gut axis: Emerging mechanisms of sarcopenia for intestinal and extra intestinal diseases 103
The Role of Antibiotics in Gut Microbiota Modulation: The Eubiotic Effects of Rifaximin 100
Locally injected Infliximab ameliorates murine DSS colitis: differences in serum and intestinal levels of drug between healthy and colitic mice 99
Intestinal gas production and gastrointestinal symptoms: from pathogenesis to clinical implication 94
Tricks for interpreting and making a good report on hydrogen and 13C breath tests 91
Gut microbial flora, prebiotics and probiotics in IBD: their current usage and utility 88
Pre- and posttherapy assessment of intestinal soluble mediators in IBD: where we stand and future perspectives 86
Pre- and posttherapy assessment of intestinal soluble mediators in IBD: where we stand and future perspectives 85
Commensal Clostridia: leading players in the maintenance of gut homeostasis 84
Gut microbial flora, prebiotics, and probiotics in IBD: their current usage and utility 83
Akkermansia muciniphila: key player in metabolic and gastrointestinal disorders 79
Dysbiosis, gut microbiota modulation and intestinal permeability in recurrent cystitis patients and concomitant gastrointestinal pathologies 79
Specific 13C functional pathways as diagnostic targets in gastroenterology breath-tests: tricks for a correct interpretation 76
Body mass index influences infliximab post-infusion levels and correlates with prospective loss of response to the drug in a cohort of inflammatory bowel disease patients under maintenance therapy with Infliximab 73
Secretome modulation of Caco-2 cell line induced by a multi-strain probiotic 69
Gut microbiota and inflammatory bowel disease: an update 68
Characterization of Sarcopenia in an IBD Population Attending an Italian Gastroenterology Tertiary Center 67
Clinical, histopathological, and immunological evaluation of a series of patients with erythema nodosum 65
Direct effect of infliximab on intestinal mucosa sustains mucosal healing: Exploring new mechanisms of action 65
Hepatocellular Carcinoma is Associated with Gut Microbiota Profile and Inflammation in Non-Alcoholic Fatty Liver Disease 64
Gut Microbiota: A Key Modulator of Intestinal Healing in Inflammatory Bowel Disease 63
Characterization of the gut-liver-muscle axis in cirrhotic patients with sarcopenia 63
Dietary Magnesium Alleviates Experimental Murine Colitis Through Upregulation of the Transient Receptor Potential Melastatin 6 Channel 62
Liver Injury, Endotoxemia, and Their Relationship to Intestinal Microbiota Composition in Alcohol-Preferring Rats 59
Intestinal permeability in physiological and pathological conditions: major determinants and assessment modalities 56
Tumor necrosis factor-α and solute carrier family 22 member 4 gene polymorphisms as potential determinants of intestinal dysbiosis 55
Combination therapy in inflammatory bowel disease – from traditional immunosuppressors towards the new paradigm of dual targeted therapy 53
SECRETOME MODULATION OF CACO2 CELL LINE INDUCED BY A MULTI-STRAIN PROBIOTIC 51
Anti-TNF-α-induced psoriasiform lesions in IBD: An abnormal immune activation or a 'patchy cutaneous' immune suppression? 49
Infliximab does not increase colonic cancer risk associated to murine chronic colitis 49
Dietary magnesium alleviates experimental murine colitis through modulation of gut microbiota 45
Evaluation of tolerability and major factors affecting the adherence to probiotic therapy in patients with irritable bowel syndrome: a prospective, observational, real-life study 44
The gut–brain axis in irritable bowel syndrome and inflammatory bowel disease 43
Combination therapy in inflammatory bowel disease – from traditional immunosuppressors towards the new paradigm of dual targeted therapy 41
Gut Dysbiosis and Fecal Calprotectin Predict Response to Immune Checkpoint Inhibitors in Patients With Hepatocellular Carcinoma 38
Increased Faecalibacterium abundance is associated with clinical improvement in patients receiving rifaximin treatment 37
Inflammatory Bowel Diseases and Sarcopenia: The Role of Inflammation and Gut Microbiota in the Development of Muscle Failure 36
Impact of the Trophic Effects of the Secretome from a Multistrain Probiotic Preparation on the Intestinal Epithelia 36
Characterization of mucosal cytokine profile in ulcerative colitis patients under conventional and anti-TNF-a treatment 34
Gut–joint axis: The role of physical exercise on gut microbiota modulation in older people with osteoarthritis 34
Intestinal Permeability and Dysbiosis in Female Patients with Recurrent Cystitis: A Pilot Study 32
Gut Microbiota Signatures Are Associated With Psychopathological Profiles in Patients With Ulcerative Colitis: Results From an Italian Tertiary IBD Center 32
Anti-tumor necrosis factor α therapy associates to type 17 helper T lymphocytes immunological shift and significant microbial changes in dextran sodium sulphate colitis 31
Bariatric procedures and microbiota: patient selection and outcome prediction 31
The thrilling journey of sars-cov-2 into the intestine: From pathogenesis to future clinical implications 31
Effect of a multistrain probiotic on leaky gut in patients with diarrhea-predominant irritable bowel syndrome (IBS-D): a pilot study 28
Influence of hepatitis C virus eradication with direct-acting antivirals on the gut microbiota in patients with cirrhosis 28
Towards a disease-associated common trait of gut microbiota dysbiosis: The pivotal role of Akkermansia muciniphila 27
The first international Rome consensus conference on gut microbiota and faecal microbiota transplantation in inflammatory bowel disease 24
Bile Acid-Related Regulation of Mucosal Inflammation and Intestinal Motility: From Pathogenesis to Therapeutic Application in IBD and Microscopic Colitis 23
MicroRNAs as Innovative Biomarkers for Inflammatory Bowel Disease and Prediction of Colorectal Cancer 22
IL-33 promotes recovery from acute colitis by inducing miR-320 to stimulate epithelial restitution and repair 21
[Microbiota and inflammatory bowel disease: an update.] 21
Ecology and Machine Learning-Based Classification Models of Gut Microbiota and Inflammatory Markers May Evaluate the Effects of Probiotic Supplementation in Patients Recently Recovered from COVID-19 19
Adverse Food Reactions in Inflammatory Bowel Disease: State of the Art and Future Perspectives 18
ToF-SIMS and principal component analysis of lipids and amino acids from inflamed and dysplastic human colonic mucosa 17
Cellular and Molecular Determinants of Biologic Drugs Resistance and Therapeutic Failure in Inflammatory Bowel Disease 12
Extrachromosomal Circular DNA: An Emerging Potential Biomarker for Inflammatory Bowel Diseases? 10
An Integrative Multi-omic Analysis defines Gut Microbiota, Mycobiota and Metabolic fingerprints in Ulcerative Colitis Patients 9
Gut microbiota, intestinal permeability, and systemic inflammation: a narrative review 9
Serial Fecal Microbiota Infusions via Colonoscopy for Active Ulcerative Colitis: A Feasibility, Safety, and Translational Monocentric Italian Study 9
Functional hypothalamic amenorrhea: gut microbiota composition and the effects of exogenous estrogen administration 8
Direct effect of infliximab on intestinal mucosa sustains mucosal healing: Exploring new mechanisms of action 7
Circular and Circulating DNA in Inflammatory Bowel Disease: From Pathogenesis to Potential Molecular Therapies 5
Totale 4.620
Salva come PNG Salva come JPEG
Categoria #
all - tutte 19.494
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.494
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020613 101 69 50 36 43 36 56 21 59 38 78 26
2020/2021390 30 35 7 35 48 25 35 10 43 20 81 21
2021/2022572 57 28 21 25 49 22 12 79 32 50 110 87
2022/20231.250 161 178 96 199 76 151 56 87 144 19 43 40
2023/2024780 46 176 29 43 32 101 49 27 43 34 85 115
2024/202526 26 0 0 0 0 0 0 0 0 0 0 0
Totale 4.620